On the other hand, it should be mentioned that CXCL1 causes the recruitment of G-MDSCs into the tumor niche [116,117,118]—cells that inhibit the action of anti-tumor lymphocytes and thus reduce the effectiveness of immunotherapy. This evidence concerns the gene CXCL1 and neoplasm.